Simon James Harrison

41PUBLICATIONS
185CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease.

|Apr 08, 2026
A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma.

Hans C Lee, Wouter J Plattel, Simon J Harrison

|Apr 06, 2026
Cytomegalovirus reactivation in patients with multiple myeloma receiving bispecific antibodies.

Enric Sastre-Escolà, Gemma K Reynolds, Michelle K Yong

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Jan 15, 2026
The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy.

Arian Lasocki, Simon J Harrison, Michael Dickinson

|Dec 23, 2025
Establishing Barriers to and Enablers of Nurse-Enabled Subcutaneous Therapy Self-Administration Programs for Patients With Myeloma: Protocol for a Qualitative Descriptive Study.

Hayley Beer, Lisa Guccione, Amit Khot

Pageof 7

Frequent Collaborators

5 joint publications

Benjamin W Teh

5 joint publications

Andrew Spencer

5 joint publications

Mark R Dowling

4 joint publications

Paul A Beavis